>
pdufa.bio

Sacituzumab Govitecan

Updated ยทnext FDA decision on the calendar

Sacituzumab Govitecan is a Gilead Sciences, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

GILD catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Gilead Sciences, Inc. (GILD). We track 3 catalyst events for this program: 2 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2026GILDReadout · Nov 2026GILDReadout · Mar 2027GILD

Questions

When is Sacituzumab Govitecan's next FDA decision or readout?

The next tracked catalyst for Sacituzumab Govitecan is a Readout in Nov 2026.

What happened at Sacituzumab Govitecan's most recent FDA decision?

No FDA decision for Sacituzumab Govitecan is in our archive yet.

Who makes Sacituzumab Govitecan?

Gilead Sciences, Inc. (GILD).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.